STOCK TITAN

Proposed insider sales at BBIO (NASDAQ: BBIO) include 30,011-share entry

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Reporting persons including Neil Kumar and related trusts reported proposed sales of Common stock under Rule 144. The filing lists multiple 10b5-1 scheduled sales between 11/20/2025 and 02/16/2026, including examples of NEIL KUMAR 30,011 shares and KUMAR HALDEA REVOCABLE TRUST 20,000 shares. The securities are Common stock held at Morgan Stanley Smith Barney LLC.

Positive

  • None.

Negative

  • None.

Insights

Rule 144/Form 144 notices list proposed affiliate sales under prearranged 10b5-1 plans.

The filing names reporting persons and multiple proposed dispositions of Common stock, with specific trade dates such as 12/15/2025 and 02/11/2026

Execution depends on plan terms and broker handling; subsequent Form 4/Form 5 or trade confirmations will show completed transactions and actual proceeds.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the BBIO Form 144 disclose?

It discloses proposed affiliate sales of Common stock under Rule 144. The filing lists multiple 10b5-1 scheduled sales dated between 11/20/2025 and 02/16/2026, with per-trade examples like 30,011 and 20,000 shares.

Who are the reported sellers in the BBIO filing?

Reported sellers include Neil Kumar and related trusts. The entries show sales by NEIL KUMAR and by KUMAR HALDEA REVOCABLE and FAMILY IRREVOCABLE TRUSTS at a Morgan Stanley Smith Barney LLC account.

Are the sales in the BBIO Form 144 completed?

No—Form 144 reports proposed or intended affiliate sales, not final trades. The filing lists scheduled 10b5-1 sales and dates; actual completion and proceeds require subsequent transaction records.

What sizes of sales are shown in the BBIO filing?

Individual scheduled sales range from 20,000 to 30,011 shares in the excerpt. Examples include NEIL KUMAR 30,011 shares on 12/15/2025 and multiple 20,000-share entries for affiliated trusts in early 2026.

Which broker or account handled the securities in the filing?

The securities are held at Morgan Stanley Smith Barney LLC. The filing lists the broker and an account address for the affected Common shares associated with the reported sales.
Bridgebio Pharma

NASDAQ:BBIO

BBIO Rankings

BBIO Latest News

BBIO Latest SEC Filings

BBIO Stock Data

14.17B
166.55M
Biotechnology
Pharmaceutical Preparations
Link
United States
PALO ALTO